Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18198425rdf:typepubmed:Citationlld:pubmed
pubmed-article:18198425lifeskim:mentionsumls-concept:C0002736lld:lifeskim
pubmed-article:18198425lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:18198425lifeskim:mentionsumls-concept:C2708283lld:lifeskim
pubmed-article:18198425pubmed:issue6lld:pubmed
pubmed-article:18198425pubmed:dateCreated2008-1-16lld:pubmed
pubmed-article:18198425pubmed:abstractTextProgressive loss of motor neurons causes Amyotrophic Lateral Sclerosis. Patients complain, most often, of progressive weakness in the distal limbs. However, weakness may manifest in any body segment (bulbar, cervical, thoracic, or lumbosacral). The diagnosis of ALS is suggested by clinical examination that reveals both upper and lower motor neuron failure. Formal diagnostic criteria have been developed and validated. Nerve conduction and electromyography studies improve diagnostic sensitivity and exclude some alternate, treatable diagnoses. Likewise, conventional imaging studies and laboratory evaluation refute other diseases that may masquerade as ALS. Experimental imaging and laboratory evaluations may improve ALS diagnosis in the future. The cause of motor neuron death is not known but inherited forms of motor neuron disease may suggest mechanisms. The goal of ALS treatment is control of the symptoms of progressive weakness, especially respiratory insufficiency and dysphagia and is best managed in an integrated clinic.lld:pubmed
pubmed-article:18198425pubmed:languageenglld:pubmed
pubmed-article:18198425pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18198425pubmed:citationSubsetIMlld:pubmed
pubmed-article:18198425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18198425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18198425pubmed:statusMEDLINElld:pubmed
pubmed-article:18198425pubmed:issn1053-8135lld:pubmed
pubmed-article:18198425pubmed:authorpubmed-author:FergusonToby...lld:pubmed
pubmed-article:18198425pubmed:authorpubmed-author:ElmanLauren...lld:pubmed
pubmed-article:18198425pubmed:issnTypePrintlld:pubmed
pubmed-article:18198425pubmed:volume22lld:pubmed
pubmed-article:18198425pubmed:ownerNLMlld:pubmed
pubmed-article:18198425pubmed:authorsCompleteYlld:pubmed
pubmed-article:18198425pubmed:pagination409-16lld:pubmed
pubmed-article:18198425pubmed:meshHeadingpubmed-meshheading:18198425...lld:pubmed
pubmed-article:18198425pubmed:meshHeadingpubmed-meshheading:18198425...lld:pubmed
pubmed-article:18198425pubmed:meshHeadingpubmed-meshheading:18198425...lld:pubmed
pubmed-article:18198425pubmed:meshHeadingpubmed-meshheading:18198425...lld:pubmed
pubmed-article:18198425pubmed:meshHeadingpubmed-meshheading:18198425...lld:pubmed
pubmed-article:18198425pubmed:year2007lld:pubmed
pubmed-article:18198425pubmed:articleTitleClinical presentation and diagnosis of amyotrophic lateral sclerosis.lld:pubmed
pubmed-article:18198425pubmed:affiliationDepartment of Neurology, Neuromuscular Division, The University of Pennsylvania School of Medicine, Philadelphia, PA 19107, USA.lld:pubmed
pubmed-article:18198425pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18198425pubmed:publicationTypeReviewlld:pubmed